Treatment to Promote Self-regulation in Children With Autism Spectrum Disorder
NCT ID: NCT05235919
Last Updated: 2024-07-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
PHASE2
50 participants
INTERVENTIONAL
2022-09-22
2025-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Transcranial Magnetic Stimulation for Evaluation and Treatment of Repetetive Behaviors in Autism
NCT01983189
Efficacy and Mechanism of Repetitive Transcranial Magnetic Stimulation in Children With Autism Spectrum Disorders
NCT05927792
Therapeutic Intervention Effects of rTMS on Children With Autism Spectrum Disorder
NCT05140356
Transcranial Magnetic Stimulation on Neural and Behavioral Facets of Social Cognition in Autism Spectrum Disorder
NCT04242355
Efficacy and Mechanism of rTMS in Children With ASD: an Open-label Clinical Trial
NCT05238298
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
repetitive transcranial magnetic stimulation (rTMS)
Participants will receive 15 rTMS sessions for 3 weeks.
repetitive transcranial magnetic stimulation (rTMS)
30 minutes rTMS session 5 days/week for 3 weeks.
Sham
Participants will receive 15 sessions of sham stimulation for 3 weeks.
Sham stimulation
30 minutes sham stimulation 5 days/week for 3 weeks.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
repetitive transcranial magnetic stimulation (rTMS)
30 minutes rTMS session 5 days/week for 3 weeks.
Sham stimulation
30 minutes sham stimulation 5 days/week for 3 weeks.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Able to participate in rTMS
Exclusion Criteria
* Children with contraindications to TMS (history of seizures, family history of seizures, metal implants)
* Co-existing neurological conditions (epilepsy, stroke, etc.)
9 Years
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre for Addiction and Mental Health
OTHER
University of Toronto
OTHER
Holland Bloorview Kids Rehabilitation Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Deryk Beal
Clinician-Scientist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Deryk Beal, PhD
Role: PRINCIPAL_INVESTIGATOR
Holland Bloorview Research Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Bloorivew Research Institute
Toronto, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
PhD
Role: backup
References
Explore related publications, articles, or registry entries linked to this study.
Oberman LM, Enticott PG, Casanova MF, Rotenberg A, Pascual-Leone A, McCracken JT; TMS in ASD Consensus Group. Transcranial magnetic stimulation in autism spectrum disorder: Challenges, promise, and roadmap for future research. Autism Res. 2016 Feb;9(2):184-203. doi: 10.1002/aur.1567. Epub 2015 Nov 4.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ASDSR01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.